Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

GSK plc American Depositary Shares (Each representing two Ordinary Shares) (NY:GSK)

59.33 -0.20 (-0.33%)
Streaming Delayed Price Updated: 12:45 PM EST, Feb 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about GSK plc American Depositary Shares (Each representing two Ordinary Shares)

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
44 45 Next >
News headline image
Researchers Working On Universal mRNA-Influenza Vaccine Aiming For Baseline Immune Memory For Diverse Strains ↗
Researchers are working on an experimental pan-influenza vaccine based on the famed mRNA technology to provide broad protection. 
Via Benzinga
News headline image
After Disappointing Confirmatory Study, GSK To Withdraw Approved Blood Cancer Drug In US ↗
 
Via Benzinga
News headline image
Dividend Income Update October 2022 ↗
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
News headline image
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says ↗
 
Via Benzinga
News headline image
GSK Touts Encouraging Data From Mid-Stage Tuberculosis Program In Drug-Susceptible Patients ↗
 
Via Benzinga
News headline image
GSK Limits Second-Line Maintenance Use Of Its Ovarian Cancer Drug To Some Populations ↗
 
Via Benzinga
News headline image
Why Vir Biotechnology Jumped Nearly 19% Today ↗
A COVID-19 partnership with a major drugmaker is producing more fruit than expected. 
Via The Motley Fool
News headline image
Citing Efficacy, GSK Stops Two Pivotal UTI Antibiotic Trials Early ↗
 
Via Benzinga
News headline image
FDA Moves Step Closer For Opioid Overdose Medication Access, Says Certain Naloxone Products Can Potentially Be Used In OTC Setting ↗
 
Via Benzinga
News headline image
Peering Into GSK's Recent Short Interest ↗
GSK's (NYSE:GSK) short percent of float has fallen 11.39% since its last report. The company recently reported that it has 13.36 million shares sold short, which is 0.7% of all regular shares that are... 
Via Benzinga
News headline image
Daily Stock Analysis: GSK plc ↗
By my dogcatcher ideal, this is a likely time to buy GSK plc shares based on their dividends for the coming year 2022-23. 
Via Talk Markets
News headline image
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster ↗
 
Via Benzinga
News headline image
Biogen, Seagen Name New CEOs — But One Biotech Stock Crumbles ↗
Biogen jumped after naming Christopher Viehbacher its CEO. David Epstein will take over at Seagen. 
Via Investor's Business Daily
News headline image
GSK's Conditionally Approved Blood Cancer Drug Fails On Progression-Free Survival Goal Over Standard Care ↗
 
Via Benzinga
News headline image
GSK Surges As Shingles Vaccine Drives Commanding Third-Quarter Beat ↗
Shingrix and specialty medicines helped drive GSK's third-quarter growth. 
Via Investor's Business Daily
News headline image
GSK Lifts Annual Outlook After Robust Vaccines, Specialty Medicine Sales In Q3 ↗
 
Via Benzinga
News headline image
GSK's Debt Overview ↗
Over the past three months, shares of GSK Inc. (NYSE:GSK) decreased by 16.74%. Before having a look at the importance of debt, let's look at how much debt GSK has. 
Via Benzinga
News headline image
Week in Review: CBC Plans $137 Million Shanghai Biopharma Complex ↗
Deals, financings, trials and approvals in Chinese biotech/biopharma this week. 
Via Talk Markets
News headline image
Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth ↗
Sales of Vir Biotechnology and GSK's Covid antibody almost tripled sales estimates. 
Via Investor's Business Daily
News headline image
Moderna's Earnings Collapsed. Time to Sell? ↗
This drugmaker's bottom line fell down a deep hole in the third quarter and investors want to know if it's time to run for the hills. 
Via The Motley Fool
News headline image
Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02 ↗
Reuters 
Via Benzinga
News headline image
Recap: GSK Q3 Earnings ↗
GSK (NYSE:GSK) reported its Q3 earnings results on Wednesday, November 2, 2022 at 05:00 AM. Here's what investors need to know about the announcement. Earnings GSK beat estimated earnings by 15.63%,... 
Via Benzinga
News headline image
GSK Pulls Plug On Late-Stage Asset Under Development For Rheumatoid Arthritis ↗
 
Via Benzinga
News headline image
GSK One Step Closer To FDA Approval For Anemia Drug For Dialysis Patients ↗
 
Via Benzinga
News headline image
GSK Walks Away From T-Cell Therapy Pact With Lyell Citing Strategic Actions ↗
 
Via Benzinga
News headline image
Earnings This Week: AMD, BP And PayPal ↗
Find out what to expect from this week's earnings calendar. 
Via Talk Markets
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
News headline image
GSK Q3 2022 Earnings Conference Call On November 2, 2022 At 08:00 AM ET ↗
GSK (NYSE:GSK) will host a conference call at 08:00 AM ET on November 2, 2022, to discuss Q3 2022 earnings results. How to Attend GSK (GSK) Conference Call Follow this link to access the live webcast. 
Via Benzinga
News headline image
Is Merck Moving Toward Another Blockbuster Drug Launch? ↗
Merck will soon share its positive phase 3 clinical trial results for a rare disease drug candidate at an upcoming event. 
Via The Motley Fool
News headline image
GSK Transfers Cell Therapy Program Rights To Adaptimmune, Terminates Second Cell Therapy Pact In A Day ↗
 
Via Benzinga
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
44 45 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.